BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported a loss of $13 million in its second quarter.
The Burlingame, California-based company said it had a loss of 44 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
In the final minutes of trading on Thursday, the company's shares hit $3.83. A year ago, they were trading at $9.72.